SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Hana Biosciences (NASDAQ:HNAB), a biopharmaceutical company focused on advancing cancer care, announced today that Mark Ahn, PhD, President & Chief Executive Officer, will present a company update at the Biotechnology Industry Organization InvestorForum on Wednesday, October 18th at 11:40am PDT in the Sea Cliff Room at The Palace Hotel, in San Francisco, CA.
